Clinical and economic impact of antibiotic resistance in developing countries: A systematic review and meta-analysis

PLoS ONE

Volumn 12, Issue 12, 2017, Pages

  Founou, Raspail Carrel ^a,b   Founou, Luria Leslie ^a,b   Essack, Sabiha Yusuf ^a  

^a UNIVERSITY OF KWAZULU NATAL   (South Africa)

^b Centre of Expertise and Biological Diagnostic of Cameroon   (Cameroon)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; CLINICAL FEATURE; COMORBIDITY; DEVELOPING COUNTRY; ECONOMIC ASPECT; HEALTH CARE COST; HEALTH PROGRAM; HUMAN; INFECTION PREVENTION; INFECTIOUS AGENT; MORTALITY RATE; MORTALITY RISK; NEWCASTLE-OTTAWA SCALE; NON COMMUNICABLE DISEASE; REVIEW; SYSTEMATIC REVIEW; META ANALYSIS;

DEVELOPING COUNTRIES; DRUG RESISTANCE, MICROBIAL; HEALTH CARE COSTS; HUMANS;

EID: 85038888254     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0189621     Document Type: Review

References (76)

1. O’Neill J. Tackling Drug-Resistant Infections Globally: Final Report And Recommendations. Review On Antimicrobial Resistance 2016.
2. World Health Organization. Antimicrobial Resistance Global Report on Surveillance. Geneva: World Health Organization; 2014.
3. Gulen TA, Guner R, Celikbilek N, Keske S, Tasyaran M. Clinical importance and cost of bacteremia caused by nosocomial multi drug resistant acinetobacter baumannii. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2015; 38:32–5.
4. World Health Organization. Global Action Plan on Antimicrobial resistance. Geneva: WHO; 2015.
5. World Health Organization. Global Priority List of Antibiotic-Resistance Bacteria to Guide Research, Discovery, and Development of New Antibiotics. Geneva: World Health Organization; 2017.
6. Årdal C, Outterson K, Hoffman SJ, Ghafur A, Sharland M, Ranganathan N, et al. International cooperation to improve access to and sustain effectiveness of antimicrobials. Lancet. 2016; 387: 296–307. https://doi.org/10.1016/S0140-6736(15)00470-5 PMID: 26603920
7. Founou LL, Founou RC, Essack SY. Antibiotic Resistance in the Food Chain: A Developing Country-Perspective. Front Microbiol. 2016; 7:1881. https://doi.org/10.3389/fmicb.2016.01881 PMID: 27933044
8. Kejela T, Bacha K. Prevalence and antibiotic susceptibility pattern of methicillin-resistant Staphylococcus aureus (MRSA) among primary school children and prisoners in Jimma Town, Southwest Ethiopia. Annals of Clinical Microbiology and Antimicrobials 2013. 2013; 12:11.
9. Njoungang LL, Nwobegahay JM, Ayangma CR, Njukeng AP, Kengne M, Abeng EM, et al. Prevalence and antibiotic resistance patterns of strains of Staphylococcus aureus isolated at the Yaounde Military Hospital, Cameroon. Microbiol Res Int. 2015; 3(4):56–63.
10. Perovic O, Iyaloo S, Kularatne R, Lowman W, Bosman N, Wadula J, et al. Prevalence and Trends of Staphylococcus aureus Bacteraemia in Hospitalized Patients in South Africa, 2010 to 2012: Laboratory-Based Surveillance Mapping of Antimicrobial Resistance and Molecular Epidemiology. PLoS One. 2015; 10(12):e0145429. https://doi.org/10.1371/journal.pone.0145429 PMID: 26719975
11. Perovic O, Koornhof HJ, Crewe-Brown HH, Duse AG, van Nierop W, Galpin JS. Pseudomonas aeruginosa bacteraemia in an academic hospital in South Africa. South African medical journal Suid-Afri-kaanse tydskrif vir geneeskunde. 2008; 98(8):626–32. PMID: 18928043
12. Perovic O, Britz E, Chetty V, Singh-Moodley A. Molecular detection of carbapenemase-producing genes in referral Enterobacteriaceae in South Africa: A short report. South African medical journal Suid-Afrikaanse tydskrif vir geneeskunde. 2016; 106(10):975–7. https://doi.org/10.7196/SAMJ.2016.v106i10.11300 PMID: 27725012
13. Perovic O, Singh-Moodley A, Duse A, Bamford C, Elliott G, Swe-Han KS, et al. National sentinel site surveillance for antimicrobial resistance in Klebsiella pneumoniae isolates in South Africa, 2010–2012. Samj South African Medical Journal. 2014; 104(8):563. https://doi.org/10.7196/samj.7617 PMID: 25213849
14. Rajagunalan S, Chakraborty S, Dhama K, SV S. Antibiotic resistance -an emerging health problem: causes, worries, challenges and solutions–A review. antibiotic resistance—an emerging health problem: causes, worries, challenges and solutions. Inter J Curr Res. 2013; 5(7):1880–92.
15. Slavcovici A, Maier C, Radulescu A. Antimicrobial Resistance Of ESKAPE-pathogens in Culture-Positive Pneumonia. FARMACIA. 2015; 63(2):201–5.
16. Kali A, Srirangaraj S, Kumar S, Divya HA, Kalyani A, Sivaraman U. Detection of metallo-beta-lactamase producing Pseudomonas aeruginosa in intensive care units. AMJ 2013; 6(12):686–93. https://doi.org/10.4066/AMJ.2013.1824 PMID: 24391679
17. Costa PO, Atta EH, Silva AR. Infection with multidrug-resistant gram-negative bacteria in a pediatric oncology intensive care unit: risk factors and outcomes. J Pediatr (Rio J). 2015; 91(5):435–41.
18. Jasovsky D, Littmann J, Zorzet A, Otto C. Antimicrobial resistance—a threat to the world’s sustainable development. UPSALA JOURNAL OF MEDICAL SCIENCES. 2016; 121:159–64. https://doi.org/10.1080/03009734.2016.1195900 PMID: 27416324
19. Thatrimontrichai A, Techato C, Dissaneevate S, Janjindamai W, Gunlawadee M, Supika K, et al. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii ventilator-associated pneumonia in the neonate: A case-case-control study. Journal of Infection and Chemotherapy. 2016; 22(7–8):444–9.
20. Tomson G, Vlad L. The need to look at antibiotic resistance from a health systems perspective. Upsala Journal of Medical Sciences. 2014; 119(2):117–24. https://doi.org/10.3109/03009734.2014.902879PMID: 24673267
21. Topeli A, Unal S, Akalin HE. Risk factors influencing clinical outcome in Staphylococcus aureus bacteraemia in a Turkish University Hospital. Int J Antimicrob Agents. 2000; 14(1):57–63. PMID: 10717502
22. Tuon FF, Gortz LW, Rocha JL. Risk factors for pan-resistant Pseudomonas aeruginosa bacteremia and the adequacy of antibiotic therapy. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases. 2012; 16(4):351–6.
23. Kelly BG, Vespermann A, Bolton DJ. The role of horizontal gene transfer in the evolution of selected foodborne bacterial pathogen. Food and Chemical Toxicology. 2009; 47 951–68. https://doi.org/10.1016/j.fct.2008.02.006 PMID: 18420329
24. Andriamanantena TS, Ratsima E, Rakotonirina HC, Randrianirina F, Ramparany L, Carod J. Dissemination of multidrug resistant acinetobacter baumannii in various hospitals of antananarivo madagascar. Ann Clin Microbiol Antimicrob. 2010; 9(17):2–7.
25. Joloba M, Bwanga F. Drug resistance in mycobacterium tuberculosis. in: Antimicrobial resistance in developing countries. BMC infectious diseases. 2010; 2010:117.
26. Ndihokubwayo JB, Yahaya AA, Desta AT, Ki-Zerbo G, Odei EA, Keita B, et al. Antimicrobial resistance in the African Region: Issues, challenges and actions proposed. African health Monitor. 2013(16).
27. Tansarli GS, Poulikakos P, Kapaskelis A, E FM. Proportion of extended-spectrum b-lactamase (ESBL)producing isolates among Enterobacteriaceae in Africa: evaluation of the evidence—systematic review. J Antimicrob Chemother. 2014.
28. Moher D, Liberati A, Tetzlaff J, Altman DG, Group TP. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLoS Med. 2009; 6(7):e1000097 https://doi.org/10.1371/journal.pmed.1000097 PMID: 19621072
29. Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, et al. Meta-analysis of Observational Studies in Epidemiology: A Proposal for Reporting. JAMA. 2000; 283(15).
30. Baran G, Erbay A, Bodur H, Onguru P, Akinci E, Balaban N, et al. Risk factors for nosocomial imipenem-resistant Acinetobacter baumannii infections. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2008; 12(1):16–21.
31. Furtado GH, Bergamasco MD, Menezes FG, Marques D, Silva A, Perdiz LB, et al. Imipenem-resistant Pseudomonas aeruginosa infection at a medical-surgical intensive care unit: risk factors and mortality. J Crit Care. 2009; 24(4):625.e9–14.
32. Serefhanoglu K, Turan H, Timurkaynak FE, Arslan H. Bloodstream infections caused by ESBL-producing E. coli and K. pneumoniae: risk factors for multidrug-resistance. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases. 2009; 13(6):403–7.
33. Cao B, Wang H, Sun H, Zhu Y, Chen M. Risk factors and clinical outcomes of nosocomial multi-drug resistant Pseudomonas aeruginosa infections. The Journal of hospital infection. 2004; 57(2):112–8. https://doi.org/10.1016/j.jhin.2004.03.021 PMID: 15183240
34. Cai XF, Sun JM, Bao LS, Li WB. Risk factors and antibiotic resistance of pneumonia caused by multidrug resistant Acinetobacter baumannii in pediatric intensive care unit. World journal of emergency medicine. 2012; 3(3):202–7. https://doi.org/10.5847/wjem.j.1920-8642.2012.03.008 PMID: 25215064
35. Yao Z, Peng Y, Chen X, Bi J, Li Y, Ye X, et al. Healthcare Associated Infections of Methicillin-Resistant Staphylococcus aureus: A Case-Control-Control Study. PLoS One. 2015; 10(10):e0140604. https://doi.org/10.1371/journal.pone.0140604 PMID: 26470023
36. Gomez RV, Zuleta TJJ. Risk factors for infection with carbapenem-resistant Klebsiella pneumoniae: a case-case-control study. Colombia medica (Cali, Colombia). 2014; 45(2):54–60.
37. Kumar A, Randhawa VS, Nirupam N, Rai Y, Saili A. Risk factors for carbapenem-resistant Acinetobacter baumanii blood stream infections in a neonatal intensive care unit, Delhi, India. J Infect Dev Ctries. 2014; 8(8):1049–54. https://doi.org/10.3855/jidc.4248 PMID: 25116673
38. Deris ZZ, Harun A, Shafei MN, Rahman RA, Johari MR. Outcomes and appropriateness of management of nosocomial Acinetobacter bloodstream infections at a teaching hospital in northeastern Malaysia. The Southeast Asian journal of tropical medicine and public health. 2009; 40(1):140–7. PMID: 19323046
39. Deris ZZ, Shafei MN, Harun A. Risk factors and outcomes of imipenem-resistant Acinetobacter bloodstream infection in North-Eastern Malaysia. Asian Pacific journal of tropical biomedicine. 2011; 1 (4):313–5. https://doi.org/10.1016/S2221-1691(11)60050-6 PMID: 23569782
40. Gomez-Barreto D, Calderon-Jaimes E, Rodriguez RS, Monteros DLE. Clinical outcome of invasive infections in children caused by highly penicillin-resistant Streptococcus pneumoniae compared with infections caused by penicillin-susceptible strains. Arch Med Res. 2000; 31(6):592–8. PMID: 11257327
41. Anunnatsiri S, Tonsawan P. Risk factors and clinical outcomes of multidrug-resistant Acinetobacter baumannii bacteremia at a university hospital in Thailand. The Southeast Asian journal of tropical medicine and public health. 2011; 42(3):693–703. PMID: 21706949
42. Anunnatsiri S, Towiwat P, Chaimanee P. Risk factors and clinical outcomes of extended spectrum beta-lactamase (ESBL)-producing Escherichia coli septicemia at Srinagarind University Hospital, Thailand. The Southeast Asian journal of tropical medicine and public health. 2012; 43(5):1169–77. PMID: 23431823
43. Chusri S, Silpapojakul K, McNeil E, Singkhamanan K, Chongsuvivatwong V. Impact of antibiotic exposure on occurrence of nosocomial carbapenem-resistant Acinetobacter baumannii infection: a case control study. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy. 2015; 21(2):90–5.
44. Inchai J, Pothirat C, Bumroongkit C, Limsukon A, Khositsakulchai W, Liwsrisaku C. Prognostic factors associated with mortality of drug-resistant Acinetobacter baumannii ventilator-associated pneumonia. Journal of Intensive Care. 2015; 3.
45. Guilarde AO, Turchi MD, Martelli CM, Primo MG. Staphylococcus aureus bacteraemia: incidence, risk factors and predictors for death in a Brazilian teaching hospital. The Journal of hospital infection. 2006; 63(3):330–6. https://doi.org/10.1016/j.jhin.2006.02.011 PMID: 16713018
46. Marra AR, Wey SB, Castelo A, Gales AC, Cal RG, Filho JR, et al. Nosocomial bloodstream infections caused by Klebsiella pneumoniae: impact of extended-spectrum beta-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence. BMC Infect Dis. 2006; 6:24. https://doi.org/10.1186/1471-2334-6-24 PMID: 16478537
47. Moreira MR, Cardoso RL, Almeida AB, Gontijo FPP. Risk factors and evolution of ventilator-associated pneumonia by Staphylococcus aureus sensitive or resistant to oxacillin in patients at the intensive care unit of a Brazilian university hospital. The Brazilian journal of infectious diseases: an official publication of the Brazilian Society of Infectious Diseases. 2008; 12(6):499–503.
48. Chen R, Yan ZQ, Feng D, Luo YP, Wang LL, Shen DX. Nosocomial bloodstream infection in patients caused by Staphylococcus aureus: drug susceptibility, outcome, and risk factors for hospital mortality. Chin Med J (Engl). 2012; 125(2):226–9.
49. Fu Q, Ye H, Liu S. Risk factors for extensive drug-resistance and mortality in geriatric inpatients with bacteremia caused by Acinetobacter baumannii. American Journal of Infection Control. 2015; 43 (8):857–60. https://doi.org/10.1016/j.ajic.2015.03.033 PMID: 25960385
50. Jia X, Ma W, Xu X, Yang S, Zhang L. Retrospective analysis of hospital-acquired linezolid-nonsuscepti-ble enterococci infection in Chongqing, China, 2011–2014. Am J Infect Control. 2015; 43(12):e101–6. https://doi.org/10.1016/j.ajic.2015.07.027 PMID: 26315061
51. Lemos EV, Hoz FP, Alvis N, Einarson TR, Quevedo E, Castaneda C, et al. Impact of carbapenem resistance on clinical and economic outcomes among patients with Acinetobacter baumannii infection in Colombia. Clinical microbiology and infection: the official publication of the European Society of Clinical Microbiology and Infectious Diseases. 2014; 20(2):174–80.
52. Chandy SJ, Naik GS, Balaji V, Jeyaseelan V, Thomas K, Lundborg CS. High cost burden and health consequences of antibiotic resistance: the price to pay. J Infect Dev Ctries. 2014; 8(9):1096–102. https://doi.org/10.3855/jidc.4745 PMID: 25212073
53. Nazer LH, Kharabsheh A, Rimawi D, Mubarak S, Hawari F. Characteristics and Outcomes of Acinetobacter baumannii Infections in Critically Ill Patients with Cancer: A Matched Case-Control Study. Microbial drug resistance (Larchmont, NY). 2015; 21(5):556–61.
54. AlJarousha AM, ElJadba AH, AlAfifi AS, ElQouqa AI. Nosocomial multidrug-resistant Acinetobacter baumannii in the neonatal intensive care unit in Gaza City, Palestine. International journal of infectious diseases: IJID: official publication of the International Society for Infectious Diseases. 2009; 13(5):623–8.
55. Ndir A, Diop A, Ka R, Faye PM, Dia-Badiane NM, Ndoye B, et al. Infections caused by extended-spectrum beta-lactamases producing Enterobacteriaceae: clinical and economic impact in patients hospitalized in 2 teaching hospitals in Dakar, Senegal. Antimicrob Resist Infect Control. 2016; 5:13. https://doi.org/10.1186/s13756-016-0114-7 PMID: 27096085
56. Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM. Risk factors for and outcomes of healthcare-associated infection due to extended-spectrum beta-lactamase-producing Escherichia coli or Klebsiella pneumoniae in Thailand. Infect Control Hosp Epidemiol. 2007; 28(7):873–6. https://doi.org/10.1086/518725 PMID: 17564993
57. Apisarnthanarak A, Kiratisin P, Saifon P, Kitphati R, Dejsirilert S, Mundy LM. Predictors of mortality among patients with community-onset infection due to extended-spectrum beta-lactamase-producing Escherichia coli in Thailand. Infect Control Hosp Epidemiol. 2008; 29(1):80–2. https://doi.org/10.1086/ 524321 PMID: 18171194
58. Chusri S, Chongsuvivatwong V, Rivera JI, Silpapojakul K, Singkhamanan K, McNeil E, et al. Clinical outcomes of hospital-acquired infection with Acinetobacter nosocomialis and Acinetobacter pittii. Antimicrob Agents Chemother. 2014; 58(7):4172–9. https://doi.org/10.1128/AAC.02992-14 PMID: 24820079
59. Jamulitrat S, Arunpan P, Phainuphong P. Attributable mortality of imipenem-resistant nosocomial Acinetobacter baumannii bloodstream infection. Journal of the Medical Association of Thailand = Chotmai-het thangphaet. 2009; 92(3):413–9. PMID: 19301737
60. Reechaipichitkul W, Assawasanti K, Chaimanee P. Risk factors and clinical outcomes of penicillin resistant S. pneumoniae community-acquired pneumonia in Khon Kaen, Thailand. The Southeast Asian journal of tropical medicine and public health. 2006; 37(2):320–6. PMID: 17124993
61. Superti SV, Augusti G, Zavascki AP. Risk factors for and mortality of extended-spectrum-beta-lacta-mase-producing Klebsiella pneumoniae and Escherichia coli nosocomial bloodstream infections. Rev Inst Med Trop Sao Paulo. 2009; 51(4):211–6. PMID: 19739001
62. Thatrimontrichai A, Apisarnthanarak A, Chanvitan P, Janjindamai W, Dissaneevate S, Maneenil G. Risk factors and outcomes of carbapenem-resistant Acinetobacter baumannii bacteremia in neonatal intensive care unit: a case-case-control study. The Pediatric infectious disease journal. 2013; 32 (2):140–5. https://doi.org/10.1097/INF.0b013e318270b108 PMID: 22935872
63. Candevir UA, Kurtaran B, Inal AS, Komur S, Kibar F, Cicekdemir HY, et al. Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infection: A Serious Threat in ICUs. Medical Science Monitor. 2015; 21:219–24. https://doi.org/10.12659/MSM.892516 PMID: 25595166
64. Amer WH. Effect of Carbapenem Resistant Metallo-Beta-Lactamase Positive Pseudomonas aeruginosa on Mortality and Morbidity of Intensive Care Unit Nosocomial Infections. Int J Curr Microbiol App Sci. 2015; 4(11):167–76.
65. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, et al. The Newcastle-Ottawa Scale (NOS) for Assessing the Quality of Nonrandomized Studies in Meta-Analyses. 2011.
66. Combes A, Luyt CE, Fagon JY, Wolff M, Trouiellet JL, Chastre J. Impact of piperacillin resistance on the outocme of pseudomonas ventillator associated pneumonia. Intensive Care Med. 2006; 32:1970–8. https://doi.org/10.1007/s00134-006-0355-7 PMID: 16957901
67. Cornejo J, Vilar CD, Pe´rez JC, Silva NSA, Herna´ndez SS, Fernandez VP. The impact of hospital-acquired infections with multidrug-resistant bacteria in an oncology intensive care unit. Inter J Infect Dis 2015; 31:31–4.
68. Schwaber MJ, Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum b-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy 2007; 60:913–20. https://doi.org/10.1093/jac/dkm318 PMID: 17848376
69. Tacconelli E, De Angelis G, Cataldo MA, Pozzi E, Cauda R. Does antibiotic exposure increase the risk of methicillin-resistant Staphylococcus aureus (MRSA) isolation? A systematic review and meta-analysis. Journal of Antimicrobial Chemotherapy. 2008; 61:26–38. https://doi.org/10.1093/jac/dkm416 PMID: 17986491
70. Santajit S, Indrawattana N. Mechanisms of Antimicrobial Resistance in ESKAPE Pathogens. BioMed Research International. 2016:8.
71. Bastug A, Kayaaslan B, Kazancioglu S, But A, Aslaner H, Akinci E, et al. Emergence of multidrug resistant isolates and mortality predictors in patients with solid tumors or hematological malignancies. J Infect Dev Ctries. 2015; 9(10):1100–7. https://doi.org/10.3855/jidc.6805 PMID: 26517485
72. Djordjevic Z, Folic M, Zecevic DR, Ilic G, Jankovic S. Risk factors for carbapenem-resistant Pseudomonas aeruginosa infection in a tertiary care hospital in Serbia. Journal of Infection in Developing Countries. 2013; 7(9):686–90. https://doi.org/10.3855/jidc.3516 PMID: 24042106
73. Inchai J, Liwsrisakun C, Theerakittikul T, Chaiwarith R, Khositsakulchai W, Pothirat C. Risk factors of multidrug-resistant, extensively drug-resistant and pandrug-resistant Acinetobacter baumannii ventilator-associated pneumonia in a Medical Intensive Care Unit of University Hospital in Thailand. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy. 2015; 21(8):570–4.
74. Laxminarayan R, Sridhar D, Blaser M, Wang M, Woolhouse M. Achieving global targets for antimicrobial resistance. Science (New York, NY). 2016.
75. Su C-H, Wang J-T, Hsiung CA, Chien L-J, Chi C-L, Yu H-T, et al. Increase of Carbapenem-Resistant Acinetobacter baumannii Infection in Acute Care Hospitals in Taiwan: Association with Hospital Antimicrobial Usage. PLoS ONE 2012; 7(5):e37788. https://doi.org/10.1371/journal.pone.0037788 PMID: 22629456
76. Doare KL, Bielicki J, Heath PT, Sharland M. Systematic Review of Antibiotic Resistance Rates Among Gram-Negative Bacteria in Children With Sepsis in Resource-Limited Countries. J Pediatric Infect Dis 2015; 4(1):11–20.